These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8324642)

  • 1. Chemocoagulation of metastatic lymph nodes using a suspension of mitomycin C-adsorbing activated carbon particles in 80% ethanol.
    Seiki K; Takahashi T; Sawai K; Okano S; Hagiwara A
    Cancer Invest; 1993; 11(4):379-87. PubMed ID: 8324642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced anticancer efficacy by use of mitomycin C adsorbed on small activated carbon particles in mice.
    Hagiwara A; Takahashi T; Ueda T; Nakagawa Y
    Jpn J Cancer Res; 1987 Apr; 78(4):405-8. PubMed ID: 3108220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced therapeutic efficacy of intralymph-nodal etoposide on distal lymph node metastases using a new dosage format--activated carbon particles adsorbing etoposide.
    Hagiwara A; Takahashi T; Sawai K; Seiki K; Ito M; Okano S; Sakakura C; Shobayashi S; Muranishi S; Tomoda H
    Anticancer Drug Des; 1992 Apr; 7(2):163-8. PubMed ID: 1575889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeting chemotherapy with activated carbon particles adsorbing anti-cancer drugs].
    Hagiwara A; Takahashi T; Kondoh S; Iwamoto A; Sawai K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1038-42. PubMed ID: 2455477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study.
    Hagiwara A; Takahashi T; Sawai K; Sakakura C; Hoshima M; Ohyama T; Ohgaki M; Imanishi T; Yamamoto A; Muranishi S
    Cancer; 1996 Nov; 78(10):2199-209. PubMed ID: 8918415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer chemotherapy for lymph nodal metastases using activated carbon particles adsorbing methotrexate].
    Hagiwara A; Takahashi T; Sawai K; Shimotsuma M; Okano S; Sakakura C; Ozaki K; Tsujimoto H; Sasaki S; Shirasu M
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1595-7. PubMed ID: 1530314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Ito M; Shobayashi S; Sasaki S; Ozaki K; Shirasu M
    Anticancer Drugs; 1992 Jun; 3(3):233-6. PubMed ID: 1525403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated carbon particles as anti-cancer drug carrier into regional lymph nodes.
    Hagiwara A; Takahashi T; Ueda T; Iwamoto A; Torii T
    Anticancer Drug Des; 1987 Apr; 1(4):313-21. PubMed ID: 2453199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced lymphatic delivery of mitomycin C conjugated with dextran.
    Takakura Y; Matsumoto S; Hashida M; Sezaki H
    Cancer Res; 1984 Jun; 44(6):2505-10. PubMed ID: 6202398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-oriented therapy for gastric cancer effective for lymph node metastasis: management of lymph node metastasis using activated carbon particles adsorbing an anticancer agent.
    Takahashi T; Sawai K; Hagiwara A; Takahashi S; Seiki K; Tokuda H
    Semin Surg Oncol; 1991; 7(6):378-83. PubMed ID: 1759087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival of patients with gastric cancer treated with intra-lymph nodal injection of activated carbon particles absorbed mitomycin C].
    Minato H; Sawai K; Takahashi T; Yamaguchi T; Hagiwara A; Yamaguchi M; Sakakibara T; Fujioka T; Ohara M; Yada Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2263-5. PubMed ID: 7944455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly developed drug delivery system using fine particles of activated charcoal for targeting chemotherapy.
    Ito K; Kiriyama K; Watanabe T; Yamauchi M; Akiyama S; Kondou K; Takagi H
    ASAIO Trans; 1990; 36(3):M199-202. PubMed ID: 2123633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity of intraperitoneally injected activated carbon particles adsorbing mitomycin C to tumor surface of Yoshida sarcoma.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Itoh M; Sasabe T
    Anticancer Drug Des; 1990 Nov; 5(4):359-69. PubMed ID: 2127181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pre-operative endoscopic infusions of an adsorbent containing mitomycin C (MMC-CH44) in stomach cancer].
    Hagiwara A; Takahashi T; Ueda T; Takeda M; Lee R; Mizuguchi N
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2558-64. PubMed ID: 6418078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis.
    Hagiwara A; Takahashi T; Ueda T; Lee R; Takeda M; Itoh T
    Anticancer Res; 1987; 7(1):105-8. PubMed ID: 3105418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationalization of lymph node dissection for gastric cancer using small sized activated carbon particles adsorbing absolute ethanol].
    Sawai K; Seiki K; Taniguchi H; Yokota T; Hagiwara A; Yamaguchi T; Takahashi T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1310-3. PubMed ID: 2586409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral treatment of pancreatic cancer with mitomycin-C adsorbed to activated carbon particles. A clinical trial on 15 cases.
    Moriai T; Makino TT; Ishii K
    Anticancer Res; 1989; 9(6):1799-804. PubMed ID: 2516716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intraperitoneal injection of mitomycin C adsorbed on activated carbon particles on induction of cytolytic peritoneal macrophages of mice.
    Sakita M; Iwamoto A; Hata K; Hagiwara A; Takahashi T
    Jpn J Cancer Res; 1989 Dec; 80(12):1252-6. PubMed ID: 2534123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles].
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Shimotsuma M; Shobayashi S; Ozaki K; Sasaki S; Tsujimoto H; Shirasu M
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1560-3. PubMed ID: 1530308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials.
    Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
    Cancer; 1987 Jan; 59(2):245-51. PubMed ID: 3100014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.